Neuroendocrine tumors - Fascination and infrequency;Tumores neuroendocrinos: Fascinación e infrecuencia

Revista Espanola de Enfermedades Digestivas

Volumn 101, Issue 3, 2009, Pages 195-208

  Varas Lorenzo, M J ^a  

^a CENTRO MÉDICO TEKNON   (Spain)

Author keywords

Carcinoid tumors; Gastro entero pancreatic endocrine tumors; Neuroendocrine pancreatic tumors; Neuroendocrine tumors

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANGIOPEPTIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; OCTREOTIDE; PASIREOTIDE; PEGINTERFERON ALPHA; STREPTOZOCIN; SUNITINIB; TEMOZOLOMIDE; THALIDOMIDE;

CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DRUG INHIBITION; ENDOCRINE DISEASE; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC POLYPECTOMY; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; LIVER METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; REVIEW; SURVIVAL RATE; TUBEROUS SCLEROSIS; VON HIPPEL LINDAU DISEASE; ARTICLE; MORTALITY;

HUMANS; NEUROENDOCRINE TUMORS; SURVIVAL RATE;

EID: 67650591296     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082009000300006     Document Type: Review

References (57)

1. Varas MJ. Endocrinología Gastroentero-pancreática. Madrid: Smar SL.; 1997.
2. Varas MJ. Tumores de los islotes pancreáticos. En: Vilardell F, et al., editores. Enfermedades Digestivas 2. Madrid-Barcelona: Aula Médica; 1998. p. 1516-1524
3. Fritscher-Raven A. Endoscopic ultrasound and neuroendocrine tumours of the pancreas. JOP 2004; 5(4): 273-281 (Pubitemid 41573880)
4. Mougey AM, Adler DG. Neuroendocrine tumors: review and clinical update. Hospital Physician 2007. p. 12-20.
5. Massironi S, Sciola V, Peracchi M, Ciafardini C, Spampatti MP, Conte D. Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol 2008; 14(35): 5377-5384
6. Buchanan KD, Johnston CF, O'Hare M, Ardill JE, Shaw C, Collins JS, et al. Neuroendocrine tumors: a European view. Am J Med 1986; 81: 14-27.
7. Kang H, O'Connell JB, Leonardi MJ, Maggard MA, MxGory ML, Ko CY. Rare tumors of the colon and rectum: a national review. Int J Colorectal Dis 2007; 22: 183-189 (Pubitemid 44964021)
8. Halfdanarson TR, Rabe KG, Rubin J, Petersen GM. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol 2008; 19(10): 1727-1733
9. Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study. Intern J Cancer 2008; 123(4): 867-873 (Pubitemid 352032414)
10. Vagefi PA, Razo O, Deshpande V, et al. Evolving patterns in the detection of pancreatic neuroendocrine tumors (PNETS): The Masschusetts General Hospital experience. Pancreas 2006; 33(4): 504 A.
11. Liu H, Zhang SZ, Wu YL, Fang HQ, Li JT, Sheng HW, et al. Diagnosis and surgical treatment of pancreatic endocrine tumors in 36 patients: a single-center report. Chin Med J 2007; 120(17): 1487-1490 (Pubitemid 47496583)
12. Jagad RB, Koshariya M, Kawamoto J, Papastratis P, Kefalourous H, Patis V, et al. Pancreatic neuroendocrine tumors: our approach. Hepato- gastroenterology 2008; 55: 275-281
13. Varas MJ. Síndrome de Zollinger-Ellison. Rev Med Univ Navarra 1995; 39: 18-23.
14. Varas MJ. Tumores endocrinos pancreáticos, ¿cuándo sospecharlos, cómo diagnosticarlos y cómo tratarlos? Revisiones en Gastroenterología 2000; 2(1): 47-55.
15. Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 2008; 135: 1469-1492
16. Kindmark H, Sundin A, Granberg D, Dunder K, Skogseid B, Janson ET, et al. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years. Med Oncol 2007; 24(3): 330-337 (Pubitemid 350135956)
17. Garbrecht N, Anlauf M, Schmitt A, Henopp T, Sipos B, Raffel A, et al. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity. Edocr Relat Cancer 2008; 15(1): 229-241
18. Berna MJ, Hoffmann K, Long SH, Serrano J, Gibril F, Jensen RT. Serum gastrin in ZES: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. Evaluation of diagnostic critera, proposal of new criteria, and correlations with clinical and tumoral features. Medicine 2006; 85(6): 331-364
19. Anderson MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM. Endoscopic ultrasound is highly accurate ad directs managements in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 2000; 95(9): 2271-2277 (Pubitemid 30707388)
20. Varas MJ, Armengol JR, Boix J, et al. Diagnóstico y localización preoperatoria de los tumores endocrinos digestivos mediante ultrasonografía endoscópica. Gastroenterol y Hepatol 1999; 22: 223-226
21. Varas MJ, Miquel JM, Maluenda MD, Boix J, Armengol JR. Preoperative detection of gastrointestinal neuroendocrine tumors using endoscopic ultrasonography. Rev Esp Enferm Dig 2006; 98: 828-836 (Pubitemid 350259112)
22. Varas MJ. Ultrasonografía endoscópica, aplicaciones diagnósticas y terapéuticas. Madrid: Ed. Médica Panamericana; 2008.
23. Santo E, Kariv R, Monges G, et al. The role of linear array endoscopic ultrasound with fine-needle aspiration in the diagnosis and preoperative evaluation of pancreatic neuroendocrine tumors -experience with 76 cases. Gastrointest Endosc 2002; 56 (4): S118.
24. Li Destri G, Regio E, Veroux M, Lanzafame S, Puleo S, Minutolo V. A rare cystic non-functioning neuroendocrine pancreatic tumor with an unusual presentation. Tumori 2006; 92: 260-263 (Pubitemid 44090309)
25. Ardengh SA, Komorowski RA, Demeure MJ, Wilson SD, Pitt HA. Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible? J Gastrointest Surg 2002; 6: 66-74.
26. Baker MS, Knuth JL, DeWitt J, LeBlanc J, Cramer H, Howard TJ, Schmidt CM, et al. Pancreatic cystic neuroendocrine tumors: preoperative diagnosis with endoscopic ultrasound and fine-needle immunocytology. Gastrointest Surg 2008; 12(3): 450-456
27. Kongkam P, Al-Haddad M, Attasaranya S, O'Neil J, Pais S, Sherman S, et al. EUS and clinical characteristics of cystic pancreatic neuroendocrine tumors. Endoscopy 2008; 40(7): 602-605 (Pubitemid 351982604)
28. Varas MJ, Tortosa F. Tumores endocrinos gastroenteropancreáticos y tratamiento con octreótida. Cirugía Española 1995; 58(4): 325-328
29. Varas MJ, Gordillo J. Tumores pancreáticos endocrinos y terapia con interferón alfa 2b. Gastroenterol y Hepatol 1992; 15(7): 394-396
30. Arnold R, Simon B, Wied M, Öberg K. Treatment of neuroendocrine GEP tumours with somatostatin analogues. Digestion 2000; 62 (Supl. 1): 84-97. (Pubitemid 30665945)
31. Pavel ME, Baum U, Hahn EG, Schuppan D, Lohmann T. Efficacy and tolerability of pegylated IFN-alpha in patients with neuroendocrine gastroenteropancreatic carcinomas. J Inteferferon Cytokine Res 2006; 26: 8-13. (Pubitemid 43201732)
32. Kulke MH, Stuart K, Enzinger PC, Ryan DP, Clark JW, Muzikansky A, et al. Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. J Clin Oncol 2006; 24: 401-406 (Pubitemid 46630459)
33. Kulke MH, Lenz HJ, Meropol NJ, Posey J, Ryan DP, Picus J, et al. Activity of sunitinib in patients with advanced neuroendocrine tumors. J Clin Oncol 2008; 26(20): 3403-3410
34. Norton JA, Fraker D, Alexander HR, Gibril F, Liewehr DJ, Venzon DJ, et al. Surgery increases survival in patients with gastrinoma. Ann Surg 2006; 244(3): 410-419 (Pubitemid 44273579)
35. Rothenstein J, Cleary SP, Pond GR, Dale D, Gallinger S, Moore MJ, et al. Neuroendocrine tumors of the gastrointestinal tract: A decade of experience at the Princess Margaret Hospital. Am J Clin Oncol 2008; 31(1): 64-70.
36. Ellison EC, Sparks J, Verducci JS, Johson JA, Muscarella P, Bllomston M, et al. 50-year appraisal of gastrinoma: recommendations for staging and treatment. J Am Coll Surg 2006; 202: 897-905. (Pubitemid 43776448)
37. Kazanjian KK, Reber HA, Hines OJ. Resection of pancreatic neuroendocrine tumors: results of 70 cases. Arch Surg 2006; 141: 765-769 (Pubitemid 44268515)
38. Böhmig M, Pape UF, Tiling N, et al. Prognostic factors in gastroenteropancreatic neuroendocrine tumors -a retrospective multivariate analysis. J Clin Oncol 2005; 23(16S): 4086.
39. Pape UF, Berndt U, Müller-Nordhorn J, Böhmig M, Roll S, Koch M, et al. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocrine-Related Cancer 2008; 15(4): 1083-1097
40. Ekebland S, Skogseid B, Dunder K, Öberg K, Eriksson B. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Research 2008; 14: 7798-7803
41. Bettini R, Boninsegna L, Mantovani W, Capelli P, Bassi C, Pederzoli P, et al. Prognostic factors at diagnosis and value of WHO classification in a mono-institucional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol 2008; 19(5): 903-908 (Pubitemid 351627305)
42. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35.825 cases in the United States. J Clin Oncol 2008; 26(18): 3063-3072
43. Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AK, et al. Neuroeendocrine tumor epidemiology: contrasting Norway and North America. Cancer 2008; 113(10): 2655-2664
44. Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM. Bronchopulmonary neuroendocrine tumors. Cancer 2008; 113(1): 5-21.
45. Younes RN, on behalf of the GETNE. Neuroendocrine tumors: A registry of 1000 patients. Rev Assoc Med Bras 2008; 54(4): 305-307
46. Martinez-Ares D, Souto J, Varas MJ, Espinós JC, Yáñez J, Abad R, et al. Endoscopic ultrasound-assisted endoscopic resection of carcinoid tumors of the gastrointestinal tract. Rev Esp Enferm Dig 2004; 96(12): 847-855 (Pubitemid 40253843)
47. Lips CJM, Lentjes EGWM, Höppener JWM. The spectrum of carcinoid tumours and carcinoid syndromes. Ann Clin Biochem 2003; 40: 612-627
48. Ramaje JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, et al.; UKNETwork for Neuroendocrine Tumours. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005; 54: iv1-iv16.
49. de Herder WW, O'Toole D, Rindi G, et al. ENETS consensus guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumors: part 2 -midgut ad hindgut tumor. Neuroendocrinology 2008; 87: 1-63.
50. Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocrine-Related Cancer 2008; 15: 409-427 (Pubitemid 351880831)
51. Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008; 9: 61-72.
52. Jensen RT. Endocrine neoplasms of the pancreas. In: Yamada T, et al., editors. Textbook of Gastroenterology. 5th ed. Oxford: Blackwell; 2008.
53. Hill JS, McPhee JT, McDade TP, Zhou Z, Sullivan ME, Whalen GF, et al. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer 2009; 115(4): 741-751
54. Strosberg J, Gardner N, Kvols L. Survival and prognostic factor análisis of 146 metastatic neuroendocrine tumors of the mid-gut. Neuroendocrinology 2009.
55. Lito P, Pantanowitz L, Marotti J, Aboulafia DM, Campbell V, Bower M, et al. Gastroenteropancreatic neuroendocrine tumors in patients with HIV infection: a trans-atlantic series (clinical investigation). Am J Med Sciences 2009; 337(1): 1-4.
56. Malagò R, D'Onofrio M, Zamboni GA, et al. Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. AJR 2009; 192: 424-430
57. Goudet P, Murat A, Cardet-Bauters C, et al. Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1. Comparative study on 21 cases among a series of 761 MEN 1 from GTE (Group des Tumeurs Endocrines). World J Surg 2009; 26: 891-896